What Happened?
Menlo Park, CA-based Adicet Bio Appointed Donald Healey as Chief Technology Officer
About the Company
Adicet Bio, Inc. is a publicly held biotechnology company (Nasdaq: ACET) discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like targeting moieties to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
About the Person
Donald Healey is Chief Technology Officer at Adicet Bio. Previously, Donald held various senior IT leadership roles in the industry.
Info Source
News
Short Profile